Citations

Clear

959 citation(s) found for "Service, F J".

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, Karoline , McGuffog, Lesley , Barrowdale, Daniel , Lee, Andrew , Soucy, Penny, Ramus, Susan J. , Terry, Mary Beth , Schmutzler, Rita K., Simard, Jacques , Pharoah, Paul D.P., Offit, Kenneth, Chenevix‐Trench, Georgia , Easton, Douglas F. , Antoniou, Antonis C, Nathanson, Katherine L. , Radice, Paolo , Jakubowska, Anna , Lubiński, Jan , Engel, Christoph , Durocher, Francine , Weitzel, Jeffrey N. , Olopade, Olufunmilayo I. , John, Esther M. , Southey, Melissa C. , Eeles, Rosalind A. , Benı́tez, Javier , Ganz, Patricia A. , Gómez, E. , Peterlongo, Paolo , Pensotti, Valeria , Giannini, Giuseppe , Jensen, Uffe Birk , Caligo, Maria A. , Ehrencrona, Hans , Adlard, Julian , Eccles, Diana , Mazoyer, Sylvie , Montagna, Marco , Teo, Soo‐Hwang , Rensburg, Elizabeth J. van , Dı́ez, Orland , Hoya, Miguel de la , Mulligan, Anna Marie , Konstantopoulou, Irene , Vijai, Joseph , Brunet, Joan , Kwong, Ava , James, Paul A. , Claes, Kathleen , Doorn, Helena C. van , Teixeira, Manuel R. , Rennert, Gad , Hulick, Peter J. , Lesueur, Fabienne , Azzollini, Jacopo , Hauke, Jan , Teulé, Àlex , Dennis, Joe , Domchek, Susan M. , Robson, Mark E. , Spurdle, Amanda B. , Mavaddat, Nasim , Neuhausen, Susan L. , Couch, Fergus J. , Antoniou, Antonis C. , Caligo, Maria A , Hulick, Peter J , James, Paul , Lesueur, Fabienne , Peterlongo, Paolo , Ramus, Susan J , Rennert, Gad , Teixeira, Manuel R , Teo, Soo H , van Rensburg, Elizabeth J , Eccles, Diana , de la Hoya, Miguel , Diez, Orland , Radice, Paolo , Weitzel, Jeffrey N , Claes, Kathleen B M , Adlard, Julian , Azzollini, Jacopo , Brunet, Joan , Eeles, Rosalind A , Ehrencrona, Hans , John, Esther M , Joseph, Vijai , Konstantopoulou, Irene , Olopade, Olufunmilayo I , Southey, Melissa C , Jakubowska, Anna , Nathanson, Katherine L , Barrowdale, Daniel , Benitez, Javier , Engel, Christoph , Montagna, Marco , Simard, Jacques , Chenevix-Trench, Georgia , Gómez-García, Encarna B , Hauke, Jan , Lubinski, Jan , Terry, Mary Beth , Kwong, Ava

Mayo Clinic

JNCI: Journal of the National Cancer Institute | November 29, 2016 | Volume: 109 | Issue: 7 | Pages: No page available

10.1093/jnci/djw302 | PMID 28376175 Get It

PTU-137 Enhanced Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by History and Diagnostic Evaluation
Sood, Ruchit , Camilleri, Michael , Gracie, DJ, Gold, M S, To, N., Ford, Alexander C. , Law, Graham Richard , Ford, Alexander C

Mayo Clinic

BSG 2016 | November 23, 2016 | Volume: No volume available | Issue: No issue available | Pages: A125.1-A125

10.1136/gutjnl-2016-312388.223 Get It

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
Dashti, S. Ghazaleh , Buchanan, Daniel D. , Jayasekara, Harindra , Ouakrim, Driss Ait , Rosty, Christophe , Winship, Ingrid , Parry, Susan, Haile, Robert W. , Gallinger, Steven , Thibodeau, Stephen N. , Lindor, Noralane M. , Jenkins, Mark A. , Win, Aung Ko , Clendenning, Mark , Macrae, Finlay , Giles, Graham G. , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Potter, John D. , Baron, John A. , Hopper, John L. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Rosty, Christophe , Winship, Ingrid M , Jayasekara, Harindra

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 4, 2016 | Volume: 26 | Issue: 3 | Pages: 366-375

10.1158/1055-9965.epi-16-0496 | PMID 27811119 Get It

Abstract Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive. Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer. Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and >28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09–2.07 and 1.69; 95% CI, 1.07–2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27–2.49 and 1.94; 95% CI, 1.19–3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk. Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers. Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366–75. ©2016 AACR.
Ruling-In Myocardial Injury and Ruling-Out Myocardial Infarction With the European Society of Cardiology 1-Hour Algorithm
Jaffe, Allan S. , White, Harvey, Jaffe, Allan S. , White, Harvey Douglas

Mayo Clinic

Circulation | October 18, 2016 | Volume: 134 | Issue: 20 | Pages: 1542-1545

10.1161/circulationaha.116.024687 | PMID 27754880 Get It

A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
Vijai, Joseph , Topka, Sabine , Villano, Danylo , Ravichandran, Vignesh , Maria, Ann, Gaddam, Pragna, Lincoln, Anne , Kazzaz, Sarah A. , Wenz, Brandon M., Carmi, Shai , Schrader, Kasmintan A. , Hart, Steven N. , Lipkin, Steve M., Walsh, Michael F. , Zhang, Liying , Lejbkowicz, Flavio, Rennert, Hedy S., Weitzel, Jeffrey N. , Daly, Mark J., Nathanson, Katherine L. , Rennert, Gad , Offit, Kenneth , Maxwell, Kara N. , Thomas, Tinu , Neuhausen, Susan L. , Stadler, Zsofia , Robson, Mark E. , Domchek, Susan M. , Couch, Fergus J. , Norton, Larry , Schrader, Intan , Rennert, Gad , Weitzel, Jeffrey N , Joseph, Vijai , Hart, Steven N , Nathanson, Katherine L , Ravichandran, Vignesh , Topka, Sabine

Mayo Clinic

Cancer Discovery | September 21, 2016 | Volume: 6 | Issue: 11 | Pages: 1267-1275

10.1158/2159-8290.cd-16-0487 | PMID 27655433 Get It

Abstract Known gene mutations account for approximately 50% of the hereditary risk for breast cancer. Moderate and low penetrance variants, discovered by genomic approaches, account for an as-yet-unknown proportion of the remaining heritability. A truncating mutation c.325C>T:p.Arg109* (R109X) in the ATP-dependent helicase ERCC3 was observed recurrently among exomes sequenced in BRCA wild-type, breast cancer–affected individuals of Ashkenazi Jewish ancestry. Modeling of the mutation in ERCC3-deficient or CRISPR/Cas9-edited cell lines showed a consistent pattern of reduced expression of the protein and concomitant hypomorphic functionality when challenged with UVC exposure or treatment with the DNA alkylating agent IlludinS. Overexpressing the mutant protein in ERCC3-deficient cells only partially rescued their DNA repair–deficient phenotype. Comparison of frequency of this recurrent mutation in over 6,500 chromosomes of breast cancer cases and 6,800 Ashkenazi controls showed significant association with breast cancer risk (ORBC = 1.53, ORER+ = 1.73), particularly for the estrogen receptor–positive subset (P < 0.007). Significance: A functionally significant recurrent ERCC3 mutation increased the risk for breast cancer in a genetic isolate. Mutated cell lines showed lower survival after in vitro exposure to DNA-damaging agents. Thus, similar to tumors arising in the background of homologous repair defects, mutations in nucleotide excision repair genes such as ERCC3 could constitute potential therapeutic targets in a subset of hereditary breast cancers. Cancer Discov; 6(11); 1267–75. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 1197
Comment on Kovatchev and Cobelli. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care 2016;39:502–510
Service, F. John

Mayo Clinic

Diabetes Care | August 23, 2016 | Volume: 39 | Issue: 9 | Pages: e156-e156

10.2337/dc16-0841 | PMID 27555632 Get It